Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy

by Branagan, A.R, Castillo, J.J, Flynn, C.A, Guerrera, M.L, Gustine, J.N, Hunter, Z.R, Kofides, A., Leventoff, C.R, Liu, X., Meid, K., Munshi, M., Patterson, C.J, Sarosiek, S.R, Treon, S.P, Tsakmaklis, N., White, T.P
Published 2022

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

by Branagan, A.R, Castillo, J.J, Demos, M.G, Flynn, C.A, Guerrera, M.L, Gustine, J.N, Hunter, Z.R, Kofides, A., Leventoff, C., Liu, X., Meid, K., Munshi, M., O’Donnell, E., Patterson, C.J, Raje, N., Sarosiek, S., Treon, S.P, Tsakmaklis, N., White, T., Xu, L., Yang, G., Yee, A.J
Published 2022

Venetoclax in Previously Treated Waldenström Macroglobulinemia

by Advani, R.H, Allan, J.N, Branagan, A.R, Castillo, J.J, Davids, M.S, Demos, M.G, Flynn, C.A, Furman, R.R, Guerrera, M.L, Hunter, Z.R, Kofides, A., Leventoff, C., Liu, X., Meid, K., Munshi, M., Patterson, C.J, Sarosiek, S., Siddiqi, T., Treon, S.P, Tsakmaklis, N., White, T.P, Xu, L., Yang, G.
Published 2022